Skip to main content
Camille Powe, MD, Endocrinology, Boston, MA

Camille Elise Powe MD

Diabetes, Gonad Disorders & Reproductive


Associate Professor, Massachusetts General Hospital, Harvard Medical School

Join to View Full Profile
  • 50 Staniford StBoston, MA 02114

  • Phone+1 617-726-8722

  • Fax+1 617-724-8534

Dr. Powe is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Massachusetts General Hospital
    Mass General Brigham/Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 2014 - 2017
  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2011 - 2014
  • Harvard Medical School
    Harvard Medical SchoolClass of 2011

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2014 - 2027
  • RI State Medical License
    RI State Medical License 2013 - 2014
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Genetic Determinants of Glycemic Traits and the Risk of Gestational Diabetes Mellitus  
    Jose C Florez, Camille E Powe, Diabetes Care

Lectures

  • Beta Cell Health in Diabetes 
    ENDO 2019 - New Orleans, LA - 3/23/2019
  • Modulation of the HPG Axis in the Female 
    ENDO 2019 - New Orleans, LA - 3/26/2019

Press Mentions

  • Insulin Beats Oral Alternatives for Gestational Diabetes Outcome
    Insulin Beats Oral Alternatives for Gestational Diabetes OutcomeJanuary 6th, 2025
  • Insulin Optimal for Gestational Diabetes Management vs. Oral Therapies
    Insulin Optimal for Gestational Diabetes Management vs. Oral TherapiesJanuary 6th, 2025
  • Gestational Diabetes During Pregnancy Is Rising. Experts Are Alarmed
    Gestational Diabetes During Pregnancy Is Rising. Experts Are AlarmedApril 8th, 2022
  • Join now to see all

Grant Support

  • Clinical Studies Investigating Use of the Bionic Pancreas in PregnancyMASSACHUSETTS GENERAL HOSPITAL2024–2029
  • Mentoring Underrepresented Researchers in Diabetes and Pregnancy InvestigationMASSACHUSETTS GENERAL HOSPITAL2023–2028
  • Glycemic Observation Using A1C for Gestational Diabetes DiagnosisMASSACHUSETTS GENERAL HOSPITAL2022–2027
  • Measuring Early Pregnancy Glycemia and Its Impact on Adverse OutcomesMASSACHUSETTS GENERAL HOSPITAL2019–2025

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: